References
- LibbyPRidkerPMMaseriAInflammation and atherosclerosisCirculation200210591135114311877368
- LintonMFFazioSMacrophages, inflammation, and atherosclerosisInt J Obes Relat Metab Disord200327Suppl 3S35S4014704742
- LessnerSMPradoHLWallerEKGalisZSAtherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine modelAm J Pathol200216062145215512057918
- ManduteanuISimionescuMInflammation in atherosclerosis: a cause or a result of vascular disorders?J Cell Mol Med20121691978199022348535
- HanssonGKInflammatory mechanisms in atherosclerosisJ Thromb Haemost20097Suppl 132833119630827
- WongWW-LDimitroulakosJMindenMDPennLZHMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia200216450851911960327
- TaylorAJKentSMFlahertyPJCoyleLCMarkwoodTTVernalisMNARBITER: Arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thicknessCirculation2002106162055206012379573
- AydinUUgurlucanMGungorFEffects of atorvastatin on vascular intimal hyperplasia: an experimental rodent modelAngiology200960337037718796450
- ThompsonPDPanzaGZaleskiATaylorBStatin-associated side effectsJ Am Coll Cardiol201667202395241027199064
- ElshamaSSEl-KenawyAE-MOsmanH-EHCurcumin improves atorvastatin-induced myotoxicity in rats: histopathological and biochemical evidenceInt J Immunopathol Pharmacol201629474275227507589
- SahebkarASaboniNPirroMBanachMCurcumin: an effective adjunct in patients with statin-associated muscle symptoms?J Cachexia Sarcopenia Muscle201781192427897416
- BanachMPattiAMGiglioRVThe role of nutraceuticals in statin intolerant patientsJ Am Coll Cardiol20187219611829957236
- Michalska-KasiczakMSahebkarAMikhailidisDPAnalysis of vitamin D levels in patients with and without statin-associated myalgia – a systematic review and meta-analysis of 7 studies with 2420 patientsInt J Cardiol201517811111625464233
- AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
- AggarwalBBHarikumarKBPotential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesInt J Biochem Cell Biol2009411405918662800
- AggarwalBBKumarABhartiACAnticancer potential of curcumin: preclinical and clinical studiesAnticancer Res2003231A36339812680238
- Simental-MendíaLEPirroMGottoAMLipid-modifying activity of curcuminoids: a systematic review and meta-analysis of randomized controlled trialsCrit Rev Food Sci Nutr201740110
- GanjaliSBlessoCNBanachMPirroMMajeedMSahebkarAEffects of curcumin on HDL functionalityPharmacol Res201711920821828192240
- OlszaneckiRJawieńJGajdaMEffect of curcumin on atherosclerosis in apoE/LDLR-double knockout miceJ Physiol Pharmacol200556462763516391419
- SahebkarAKotaniKSerbanCStatin therapy reduces plasma endothelin-1 concentrations: a meta-analysis of 15 randomized controlled trialsAtherosclerosis2015241243344226074317
- SerbanCSahebkarAUrsoniuSMikhailidisDPRizzoMA systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrationsSci Rep2015241199
- KhadkaPRoJKimHPharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailabilityAsian J Pharm201496304316
- KalashnikovaIMazarJNealCJNanoparticle delivery of cur-cumin induces cellular hypoxia and ROS-mediated apoptosis via modulation of Bcl-2/Bax in human neuroblastomaNanoscale2017929103751038728702620
- XuPYuHZhangZHydrogen-bonded and reduction-responsive micelles loading atorvastatin for therapy of breast cancer metastasisBiomaterials201435267574758724899527
- AlupeiMCLicareteEPatrasLBanciuMLiposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stressCancer Lett20153562 Pt B94695225444912
- MalamYLoizidouMSeifalianAMLiposomes and nanoparticles: nano-sized vehicles for drug delivery in cancerTrends Pharmacol Sci2009301159259919837467
- YinTWangPLiJTumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomesBiomaterials201435225932594324746965
- HeCTangZTianHChenXCo-delivery of chemotherapeutics and proteins for synergistic therapyAdv Drug Deliv Rev201698647626546464
- TakaraKHatakeyamaHKibriaGOhgaNHidaKHarashimaHSize-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapyJ Control Release2012162122523222728515
- LiuJJiangXAshleyCBrinkerCJElectrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and deliveryJ Am Chem Soc2009131227567756919445508
- SapraPTyagiPAllenTLigand-targeted liposomes for cancer treatmentCurr Drug Delivery200524369381
- StefanickJFAshleyJDKiziltepeTBilgicerBA systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomesACS Nano2013742935294723421406
- YangYYangYXieXDual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting deliveryBiomaterials201548849625701034
- ChenCDuanZYuanYPeptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTBACS Appl Mater Interfaces2017975864587328128553
- EvertsMSchraaAJde LeijLMeijerDKFMolemaGVascular endothelium in inflamed tissue as a target for site selective delivery of drugsMolemaGMeijerDKFDrug Targeting: Organ-Specific StrategiesWeinheimWiley-VCH200112171197
- LeusNGTalmanEGRamanaPEffective siRNA delivery to inflamed primary vascular endothelial cells by anti-E-selectin and anti-VCAM-1 PEGylated SAINT-based lipoplexesInt J Pharm20144591–2405024239833
- MoraneLHLyTNicolasRProinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor/CD74 complexAm J Resp Crit Care20151928983997
- JubeliEMoineLVergnaud-GauduchonJBarrattGE-selectin as a target for drug delivery and molecular imagingJ Control Release2012158219420621983284
- BhaskarVLawDAIbsenEE-selectin up-regulation allows for targeted drug delivery in prostate cancerCancer Res200363196387639414559828
- GhalandarlakiNAlizadehAMAshkani-EsfahaniSNanotechnology-applied curcumin for different diseases therapyBiomed Res Int20143394264
- KumarNChaurasiaSPatelRRKumarVMishraBDevelopment and optimization of atorvastatin calcium loaded oral biodegradable polymeric nanoparticles using central composite designAdv Sci Lett2014205984993
- GuLOkadaYClintonSKAbsence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient miceMol Cell1998222752819734366
- MichelsenKSWongMHShahPKLack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein EProc Natl Acad Sci U S A200410129106791068415249654
- MannAPTanakaTSomasunderamALiuXGorensteinDGFerrariMSite-specific drug delivery: E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrowAdv Mater20112336H284
- DeguchiJOAikawaMTungCHInflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivoCirculation20061141556216801460
- LiCZhangWJFreiBQuercetin inhibits LPS-induced adhesion molecule expression and oxidant production in human aortic endothelial cells by p38-mediated Nrf2 activation and antioxidant enzyme inductionRedox Biol2016910411327454768
- WuTChenXWangYAortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammationNanomed-Nanotechnol201814722152226
- PaolettiRGottoAMJrHajjarDPInflammation in atherosclerosis and implications for therapyCirculation200410923 Suppl 1III-20III-2615198962
- ViedtCVogelJAthanasiouTMonocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1Arterioscler Thromb Vasc Biol200222691492012067898
- HasanSTZinggJ-MKwanPNobleTSmithDMeydaniMCurcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient miceAtherosclerosis20142321405124401215
- VallianouNGEvangelopoulosASchizasNKazazisCPotential anticancer properties and mechanisms of action of curcuminAnticancer Res201535264525667441
- HanssonGKImmune and inflammatory mechanisms in the development of atherosclerosisBr Heart J1993691 SupplS38S418427763
- Emini VeseliBPerrottaPde MeyerGRAAnimal models of atherosclerosisEur J Pharmacol201781631328483459
- GholizadehSVisweswaranGStormGHenninkWEKampsJKokRJE-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cellsInt J Pharmaceut2017542759770
- MaSTianXYZhangYE-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosisSci Rep2016612291026956647
- BasnetPHussainHThoISkalko-BasnetNLiposomal delivery system enhances anti-inflammatory properties of curcuminJ Pharm Sci2012101259860921989712
- MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res200342646347814559067
- LiYChengQJiangQEnhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNAJ Control Release2014176110411424365128
- LiYLiuRShiYZhangZZhangXRuiyuanLZwitterionic poly(carboxybetaine)-based cationic liposomes for effective delivery of small interfering RNA therapeutics without accelerated blood clearance phenomenonTheranostics20155658359625825598